Epibiotech Co., Ltd. (XKON:446440)
9,540.00
-1,680.00 (-14.97%)
At close: Nov 12, 2026
| Market Cap | 22.01B -39.2% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,171 |
| Open | 9,540.00 |
| Previous Close | 11,220.00 |
| Day's Range | 9,540.00 - 9,540.00 |
| 52-Week Range | 9,540.00 - 21,950.00 |
| Beta | 0.31 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |